PRESS RELEASE published on 06/25/2025 at 18:00, 8 months 28 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV
BRIEF published on 06/19/2025 at 08:35, 9 months 4 days ago Oxurion to Acquire Preclinical Microbiology CRO in Toulouse Acquisition Diversification Toulouse Oxurion Microbiology CRO
BRIEF published on 06/19/2025 at 08:35, 9 months 4 days ago Oxurion acquiert une CRO en microbiologie préclinique à Toulouse Acquisition Diversification Toulouse Oxurion CRO En Microbiologie
PRESS RELEASE published on 06/19/2025 at 08:30, 9 months 4 days ago Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een preklinische microbiologie-CRO om zich te diversifiëren en zijn aanwezigheid in de regio Toulouse te versterken Oxurion NV, een biofarmaceutisch bedrijf in Leuven, kondigt intentieovereenkomst voor de overname van onderneming gespecialiseerd in microbiologische diensten aan, ter versterking van expertise en strategie Stratégie Overname Oxurion NV Biofarmaceutisch Microbiologische Diensten
PRESS RELEASE published on 06/19/2025 at 08:30, 9 months 4 days ago Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology
PRESS RELEASE published on 06/19/2025 at 08:30, 9 months 4 days ago Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO de services précliniques en microbiologie afin de se diversifier et de renforcer sa présence en région toulousaine Oxurion NV signe une lettre d'intention pour l'acquisition de 70% d'une société spécialisée en microbiologie appliquée à la santé humaine et animale, dermocosmétiques et nutraceutiques Acquisition Biopharmaceutique Lettre D'intention Oxurion NV Microbiologie Appliquée
BRIEF published on 06/18/2025 at 18:05, 9 months 5 days ago Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
BRIEF published on 06/18/2025 at 18:05, 9 months 5 days ago Oxurion annonce une notification de transparence de la part d'Atlas Special Opportunities II LLC Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas Structure De Propriété
PRESS RELEASE published on 06/18/2025 at 18:00, 9 months 5 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE published on 06/18/2025 at 18:00, 9 months 5 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC, verlaagt aandeel tot onder drempel 20%. Biofarmaceutisch bedrijf in Leuven kondigt belangrijke ontwikkeling aan Transparantiekennisgeving Oxurion NV Biofarmaceutisch België Atlas Special Opportunities II LLC
Published on 03/23/2026 at 22:40, 4 hours 37 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 4 hours 47 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 5 hours 17 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 5 hours 59 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/24/2026 at 02:00, 1 hour 16 minutes ago Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 2 hours 21 minutes ago mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
Published on 03/24/2026 at 00:09, 3 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 5 hours 11 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 6 hours 11 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 19:08, 8 hours 8 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 8 hours 8 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 8 hours 39 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 9 hours 31 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 9 hours 31 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde